Trials / Completed
CompletedNCT03795818
IPT-A for Adolescents With PTSD Symptoms
An Open Clinical Trial of Interpersonal Psychotherapy for Adolescents With PTSD Symptoms
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- New York State Psychiatric Institute · Academic / Other
- Sex
- All
- Age
- 13 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
In the present study, the investigators propose to 1) adapt Interpersonal Psychotherapy for Adolescents (IPT-A) as an intervention for adolescents who report elevated symptoms of posttraumatic stress disorder (PTSD) and/or meet Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM-5) criteria for PTSD; and 2) conduct a small open pilot study of IPT-A for PTSD. Ten adolescents ages 13 to 18 who meet DSM-5 criteria for a PTSD diagnosis or have elevated symptoms of PTSD (Child PTSD Symptom Scale \[CPSS-5\] ≥ 31) will be treated with 14-16 weeks of an adapted version of IPT-A. If participants have evidenced a decrease in PTSD symptoms (CPSS-5 \< 31) they will also receive 3 months of once a month maintenance treatment and be assessed by a clinician evaluator at the conclusion of the 3 monthly sessions. If participants have not evidenced a decrease in PTSD symptoms (CPSS-5 ≥ 31), they will be referred for alternative treatments in the community and be assessed by a clinician evaluator 3 months following the completion of IPT-A. All evaluations and therapy sessions will be done over telehealth platform until able to be done in person.
Detailed description
Please see the brief summary for study description.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Interpersonal Psychotherapy for Adolescents | IPT-A is a psychosocial intervention for adolescents that focuses on improving interpersonal relationships that seem to be associated with the psychiatric symptoms. |
Timeline
- Start date
- 2019-08-01
- Primary completion
- 2023-06-12
- Completion
- 2023-06-12
- First posted
- 2019-01-08
- Last updated
- 2024-02-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03795818. Inclusion in this directory is not an endorsement.